InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Gutfreund John Peter. Director active across 1 company, notably OncoCyte Corp. Cumulatively, 4 reports have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €23k. Activity tracked since 15 August 2022. The latest transaction was filed on 30 June 2023 (J). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
A declarant linked to OncoCyte Corp. The record shows 4 filings in total. In the 4 sampled recent filings, buys total EUR 23321, sells total EUR 0, and the period runs from 2022-08-17 to 2023-07-03. The modal transaction nature is Attribution.